BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33874885)

  • 1. Effect of IL-15 addition on asbestos-induced suppression of human cytotoxic T lymphocyte induction.
    Kumagai-Takei N; Nishimura Y; Matsuzaki H; Lee S; Yoshitome K; Ito T; Otsuki T
    Environ Health Prev Med; 2021 Apr; 26(1):50. PubMed ID: 33874885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Suppressed Induction of Human Mature Cytotoxic T Lymphocytes Caused by Asbestos Is Not due to Interleukin-2 Insufficiency.
    Kumagai-Takei N; Nishimura Y; Matsuzaki H; Lee S; Yoshitome K; Hayashi H; Otsuki T
    J Immunol Res; 2016; 2016():7484872. PubMed ID: 27975069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of asbestos exposure on differentiation of cytotoxic T lymphocytes in mixed lymphocyte reaction of human peripheral blood mononuclear cells.
    Kumagai-Takei N; Nishimura Y; Maeda M; Hayashi H; Matsuzaki H; Lee S; Hiratsuka J; Otsuki T
    Am J Respir Cell Mol Biol; 2013 Jul; 49(1):28-36. PubMed ID: 23449737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of asbestos exposure on differentiation and function of cytotoxic T lymphocytes.
    Kumagai-Takei N; Nishimura Y; Maeda M; Hayashi H; Matsuzaki H; Lee S; Yoshitome K; Ito T; Otsuki T
    Environ Health Prev Med; 2020 Oct; 25(1):59. PubMed ID: 33032525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.
    Tamang DL; Redelman D; Alves BN; Vollger L; Bethley C; Hudig D
    Cytokine; 2006 Nov; 36(3-4):148-59. PubMed ID: 17188506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of IL-17 production from human peripheral blood CD4+ cells by asbestos exposure.
    Maeda M; Chen Y; Lee S; Kumagai-Takei N; Yoshitome K; Matsuzaki H; Yamamoto S; Hatayama T; Ikeda M; Nishimura Y; Otsuki T
    Int J Oncol; 2017 Jun; 50(6):2024-2032. PubMed ID: 28498408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease in Intracellular Perforin Levels and IFN-
    Kumagai-Takei N; Nishimura Y; Matsuzaki H; Lee S; Yoshitome K; Otsuki T
    J Immunol Res; 2018; 2018():4391731. PubMed ID: 30426024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-12 stimulates CTLs to secrete exosomes capable of activating bystander CD8
    Li L; Jay SM; Wang Y; Wu SW; Xiao Z
    Sci Rep; 2017 Oct; 7(1):13365. PubMed ID: 29042682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil].
    Chi PD; Li L; Fan YY; Wu CY
    Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of 4-1BB (CD137) in the functional activation of cord blood CD28(-)CD8(+) T cells.
    Kim YJ; Brutkiewicz RR; Broxmeyer HE
    Blood; 2002 Nov; 100(9):3253-60. PubMed ID: 12384425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of human alloreactive CD4+ and CD8+ T cells in vitro.
    Nikolaeva N; Uss E; van Leeuwen EM; van Lier RA; ten Berge IJ
    Transplantation; 2004 Sep; 78(6):815-24. PubMed ID: 15385799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional CD4(+) and CD8(+) T-cell responses induced by autologous mitomycin C treated Epstein-Barr virus transformed lymphoblastoid cell lines.
    Meij P; Bloemena E; Palmen N; Brink A; Vervoort MB; Meijer CJ; Middeldorp JM
    Cell Immunol; 2001 Feb; 208(1):25-33. PubMed ID: 11277616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional properties of CD8(+) lymphocytes in patients with pleural plaque and malignant mesothelioma.
    Kumagai-Takei N; Nishimura Y; Maeda M; Hayashi H; Matsuzaki H; Lee S; Kishimoto T; Fukuoka K; Nakano T; Otsuki T
    J Immunol Res; 2014; 2014():670140. PubMed ID: 25045719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of cord blood CD8+ T-cell effector differentiation by TGF-beta1 and 4-1BB costimulation.
    Kim YJ; Stringfield TM; Chen Y; Broxmeyer HE
    Blood; 2005 Jan; 105(1):274-81. PubMed ID: 15353478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of sodium arsenite during the activation of human CD4+ and CD8+ T lymphocytes.
    Tenorio EP; Saavedra R
    Int Immunopharmacol; 2005 Dec; 5(13-14):1853-69. PubMed ID: 16275621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 15-Deoxyspergualin inhibits interleukin 6 production in in vitro stimulated human lymphocytes.
    Borg AJ; Kumagai-Braesch M; Möller E
    Transpl Immunol; 1996 Jun; 4(2):133-43. PubMed ID: 8843590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-27 increases the proliferation and effector functions of human naïve CD8+ T lymphocytes and promotes their development into Tc1 cells.
    Schneider R; Yaneva T; Beauseigle D; El-Khoury L; Arbour N
    Eur J Immunol; 2011 Jan; 41(1):47-59. PubMed ID: 21182076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 15 promotes antigen-independent in vitro expansion and long-term survival of antitumor cytotoxic T lymphocytes.
    Lu J; Giuntoli RL; Omiya R; Kobayashi H; Kennedy R; Celis E
    Clin Cancer Res; 2002 Dec; 8(12):3877-84. PubMed ID: 12473603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human CD8+ T lymphocytes can be divided into CD45RA+ and CD45RO+ cells with different requirements for activation and differentiation.
    de Jong R; Brouwer M; Miedema F; van Lier RA
    J Immunol; 1991 Apr; 146(7):2088-94. PubMed ID: 1826015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.